18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Genome-wide discovery of novel M1T1 group A streptococcal determinants important for fitness and virulence during soft-tissue infection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Group A Streptococcus remains a significant human pathogen causing a wide array of disease ranging from self-limiting to life-threatening invasive infections. Epithelium (skin or throat) colonization with progression to the subepithelial tissues is the common step in all GAS infections. Here, we used transposon-sequencing (Tn-seq) to define the GAS 5448 genetic requirements for in vivo fitness in subepithelial tissue. A near-saturation transposon library of the M1T1 GAS 5448 strain was injected subcutaneously into mice, producing suppurative inflammation at 24 h that progressed to prominent abscesses with tissue necrosis at 48 h. The library composition was monitored en masse by Tn-seq and ratios of mutant abundance comparing the output (12, 24 and 48 h) versus input (T 0) mutant pools were calculated for each gene. We identified a total of 273 sub cutaneous fitness ( scf) genes with 147 genes (55 of unknown function) critical for the M1T1 GAS 5448 fitness in vivo; and 126 genes (53 of unknown function) potentially linked to in vivo fitness advantage. Selected scf genes were validated in competitive subcutaneous infection with parental 5448. Two uncharacterized genes, scfA and scfB, encoding putative membrane-associated proteins and conserved among Gram-positive pathogens, were further characterized. Defined scfAB mutants in GAS were outcompeted by wild type 5448 in vivo, attenuated for lesion formation in the soft tissue infection model and dissemination to the bloodstream. We hypothesize that scfAB play an integral role in enhancing adaptation and fitness of GAS during localized skin infection, and potentially in propagation to other deeper host environments.

          Author summary

          The WHO ranks the Group A Streptococcus (GAS) in the top 10 leading causes of morbidity and mortality from infectious diseases worldwide. GAS is a strict human pathogen causing both benign superficial infections as well as life-threatening invasive diseases. All GAS infections begin by colonization of an epithelium (throat or skin) followed by propagation into subepithelial tissues. The genetic requirements for M1T1 GAS 5448 within this niche were interrogated by in vivo transposon sequencing (Tn-seq), identifying 273 sub cutaneous fitness ( scf) genes with 108 of those previously of “unknown function”. Two yet uncharacterized genes, scfA and scfB, were shown to be critical during GAS 5448 soft tissue infection and dissemination into the bloodstream. Thus, this study improves the functional annotation of the GAS genome, providing new insights into GAS pathophysiology and enhancing the development of novel GAS therapeutics.

          Related collections

          Most cited references87

          • Record: found
          • Abstract: found
          • Article: not found

          The global burden of group A streptococcal diseases.

          The global burden of disease caused by group A streptococcus (GAS) is not known. We review recent population-based data to estimate the burden of GAS diseases and highlight deficiencies in the available data. We estimate that there are at least 517,000 deaths each year due to severe GAS diseases (eg, acute rheumatic fever, rheumatic heart disease, post-streptococcal glomerulonephritis, and invasive infections). The prevalence of severe GAS disease is at least 18.1 million cases, with 1.78 million new cases each year. The greatest burden is due to rheumatic heart disease, with a prevalence of at least 15.6 million cases, with 282,000 new cases and 233,000 deaths each year. The burden of invasive GAS diseases is unexpectedly high, with at least 663,000 new cases and 163,000 deaths each year. In addition, there are more than 111 million prevalent cases of GAS pyoderma, and over 616 million incident cases per year of GAS pharyngitis. Epidemiological data from developing countries for most diseases is poor. On a global scale, GAS is an important cause of morbidity and mortality. These data emphasise the need to reinforce current control strategies, develop new primary prevention strategies, and collect better data from developing countries.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tn-seq; high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms

            Biological pathways are structured in complex networks of interacting genes. Solving the architecture of such networks may provide valuable information, such as how microorganisms cause disease. Here we present a method (Tn-seq) for accurately determining quantitative genetic interactions on a genome-wide scale in microorganisms. Tn-seq is based on the assembly of a saturated Mariner transposon insertion library. After library selection, changes in frequency of each insertion mutant are determined by sequencing of the flanking regions en masse. These changes are used to calculate each mutant’s fitness. Fitness was determined for each gene of the gram-positive bacterium Streptococcus pneumoniae, a causative agent of pneumonia and meningitis. A genome-wide screen for genetic interactions identified both alleviating and aggravating interactions that could be further divided into seven distinct categories. Due to the wide activity of the Mariner transposon, Tn-seq has the potential to contribute to the exploration of complex pathways across many different species.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Identifying genetic determinants needed to establish a human gut symbiont in its habitat.

              The human gut microbiota is a metabolic organ whose cellular composition is determined by a dynamic process of selection and competition. To identify microbial genes required for establishment of human symbionts in the gut, we developed an approach (insertion sequencing, or INSeq) based on a mutagenic transposon that allows capture of adjacent chromosomal DNA to define its genomic location. We used massively parallel sequencing to monitor the relative abundance of tens of thousands of transposon mutants of a saccharolytic human gut bacterium, Bacteroides thetaiotaomicron, as they established themselves in wild-type and immunodeficient gnotobiotic mice, in the presence or absence of other human gut commensals. In vivo selection transforms this population, revealing functions necessary for survival in the gut: we show how this selection is influenced by community composition and competition for nutrients (vitamin B(12)). INSeq provides a broadly applicable platform to explore microbial adaptation to the gut and other ecosystems.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: SoftwareRole: VisualizationRole: Writing – review & editing
                Role: InvestigationRole: Writing – review & editing
                Role: InvestigationRole: ValidationRole: Writing – review & editing
                Role: InvestigationRole: ValidationRole: Writing – review & editing
                Role: InvestigationRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: ResourcesRole: Writing – review & editing
                Role: Formal analysisRole: ResourcesRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: Funding acquisitionRole: ResourcesRole: Writing – review & editing
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: Writing – original draftRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS Pathog
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, CA USA )
                1553-7366
                1553-7374
                23 August 2017
                August 2017
                : 13
                : 8
                : e1006584
                Affiliations
                [1 ] Department of Cell Biology & Molecular Genetics and Maryland Pathogen Research Institute, University of Maryland, College Park, Maryland, United States of America
                [2 ] Center for Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland, United States of America
                [3 ] Graduate Program in Life Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
                [4 ] Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
                [5 ] Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
                [6 ] Department of Microbial Pathogenesis, Dental School, University of Maryland, Baltimore, Maryland, United States of America
                [7 ] Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
                Boston Children's Hospital, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                [¤]

                Current address: Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, United States of America

                Author information
                http://orcid.org/0000-0001-8040-2605
                http://orcid.org/0000-0001-6725-5081
                http://orcid.org/0000-0002-5788-1481
                http://orcid.org/0000-0002-0376-1337
                http://orcid.org/0000-0002-0615-3257
                http://orcid.org/0000-0001-7970-3312
                http://orcid.org/0000-0002-4769-4463
                Article
                PPATHOGENS-D-17-01298
                10.1371/journal.ppat.1006584
                5584981
                28832676
                aa66f39a-dc07-4d0d-a67f-cd176ab52747
                © 2017 Le Breton et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 16 June 2017
                : 15 August 2017
                Page count
                Figures: 8, Tables: 0, Pages: 28
                Funding
                Funded by: NIH, National Institute of Allergy and Infectious Diseases (US)
                Award ID: AI047928
                Award Recipient :
                Funded by: NIH, National Institute of Allergy and Infectious Diseases (US)
                Award ID: AI094773
                Award Recipient :
                Funded by: University of Maryland System
                Award ID: 2014-2015 Seed Grant
                Award Recipient :
                Funded by: NIH, National Institute of Allergy and Infectious Diseases (US)
                Award ID: AI134079
                Award Recipient :
                KSM, YLB, GSS, and EI were supported by grants (AI047928, AI134079) from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. NMES and ATB were supported by an award (AI094773) from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Initial support was provided by a University of Maryland, Baltimore (UMB) and University of Maryland at College Park UMCP Seed Grant (2014/2015) awarded to YLB, KSM, and MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Genetics
                Genomics
                Animal Genomics
                Mammalian Genomics
                Medicine and Health Sciences
                Infectious Diseases
                Soft Tissue Infections
                Biology and Life Sciences
                Molecular Biology
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Library Screening
                Genomic Library Screening
                Research and Analysis Methods
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Library Screening
                Genomic Library Screening
                Biology and Life Sciences
                Genetics
                Gene Identification and Analysis
                Genetic Screens
                Biology and Life Sciences
                Evolutionary Biology
                Population Genetics
                Gene Pool
                Biology and Life Sciences
                Genetics
                Population Genetics
                Gene Pool
                Biology and Life Sciences
                Population Biology
                Population Genetics
                Gene Pool
                Medicine and health sciences
                Infectious diseases
                Bacterial diseases
                Group A streptococcal infection
                Medicine and Health Sciences
                Dermatology
                Skin Infections
                Medicine and Health Sciences
                Infectious Diseases
                Skin Infections
                Biology and Life Sciences
                Molecular Biology
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Library Screening
                Research and Analysis Methods
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Library Screening
                Custom metadata
                vor-update-to-uncorrected-proof
                2017-09-05
                All data except for the raw sequencing reads are provided with the submitted materials. Illumina sequencing reads from the RNA-seq and Tn-seq analyses were deposited in the NCBI Sequence Read Archive (SRA) under the accession number (PRJNA391181).

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article